Claustrum Volume Is Reduced in Multiple Sclerosis and Predicts Disability by Nicole Shelley, Bradley Judge, Dmitriy A. Yablonskiy, Robert T. Naismith, Matthew R. Brier, Anne H. Cross

Get full text

Retrospective OCT Analysis of Sphingosine-1-Phosphate Modulator Fingolimod in Multiple Sclerosis by Wilson X. Wang, MD, MPhil, Helen Rossmiller, BS, Henok Getahun, BS, Aditya Santoki, BS, Dana C. Perantie, MPH, Robert T. Naismith, MD, Rajendra S. Apte, MD, PhD

Get full text

Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study by Scott D. Newsome, Lawrence Goldstick, Derrick S. Robertson, James D. Bowen, Robert T. Naismith, Ben Townsend, Catarina Figueiredo, Heidemarie Kletzl, Mylene Giraudon, Oscar Bortolami, Dusanka Zecevic, Caroline Giacobino, Susanne Clinch, Yun‐An Shen, Gurpreet Deol-Bhullar, Robert A. Bermel

Get full text